Trial Profile
Acute Changes in Intraocular Cytokines After Intravitreal Bevacizumab
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic retinopathy
- Focus Pharmacodynamics
- 26 Sep 2011 New trial record